Ownership

Erika Jones

Insider Reports History

Entity: Individual
Location: C/O Black Diamond Therapeutics, Inc., One Main Street, 10 Th Floor, Cambridge, MA
Signature: /s/ Brent Hatzis-Schoch, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erika Jones:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Black Diamond Therapeutics, Inc.	Officer Title: Senior Vice President, Finance and Corporate Controller	Common Stock	85.2K	$213K	$2.50	Jan 30, 2025	Direct
Black Diamond Therapeutics, Inc.	Officer Title: Senior Vice President, Finance and Corporate Controller	Stock Option (Right to Buy)	125K			Jan 30, 2025	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by Erika Jones

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
BDTX	Black Diamond Therapeutics, Inc.	Jan 30, 2025	2	$0	4	Jan 31, 2025	Officer Title: Senior Vice President, Finance and Corporate Controller
BDTX	Black Diamond Therapeutics, Inc.	Feb 14, 2024	1	$0	4	Feb 15, 2024	Officer Title: Vice President, Finance and Corporate Controller
BDTX	Black Diamond Therapeutics, Inc.	Feb 13, 2023	2	$0	4	Feb 15, 2023	Officer Title: Vice President, Finance and Corporate Controller
BDTX	Black Diamond Therapeutics, Inc.	Feb 15, 2022	2	$0	4	Feb 17, 2022	Officer Title: Vice President, Finance and Corporate Controller
BDTX	Black Diamond Therapeutics, Inc.	Nov 18, 2021	0	$0	3	Nov 29, 2021	Officer Title: Vice President, Finance and Corporate Controller